Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Oncology|June 17, 2016
Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expressionZoran Culig, Jan Pencik, Olaf Merkel, et al.
Swiss Medical Weekly|December 23, 2015
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancerJan Pencik, Robert Wiebringhaus, Martin Susani, et al.
Critical Reviews in Oncology/Hematology|March 19, 2025
The impact of urine biomarkers for prostate cancer detection-A systematic state of the art reviewStefan Plas, Felix Melchior, Gerhard P Aigner, et al.
Cytokine|June 29, 2016
JAK-STAT signaling in cancer: From cytokines to non-coding genomeJan Pencik, Ha Thi Thanh Pham, Johannes Schmoellerl, et al.
Cancers|December 10, 2021
Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate CancerRobert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, et al.
The Journal of Pathology|June 13, 2017
A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumoursLucila Sackmann Sala, Florence Boutillon, Giulia Menara, et al.
The Journal of Clinical Investigation|December 5, 2017
STAT5BN642H is a driver mutation for T cell neoplasiaHa Thi Thanh Pham, Barbara Maurer, Michaela Prchal-Murphy, et al.
Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease|July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Cell Death & Disease|August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.
Pageof 2